WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
BPTH
BIO-PATH HOLDINGS INC
$1.77M-375.70%-248.60%-1,223.59%-1,019.90%6.301.60N/AN/AN/A
BIVI
BIOVIE INC
$19.54M-332.20%-137.90%-522.71%-688.30%1.871.47N/AN/AN/A
ANEB
ANEBULO PHARMACEUTICALS INC
$76.50M-109.40%-98.40%-161.24%1,888.20%0.166.73N/AN/AN/A
RENB
RENOVARO INC
$215.50M-81.30%-65.30%-91.22%1,451.90%0.330.18N/AN/AN/A
CTCX
CARMELL CORP
$42.34M-1,325.20%-38.10%-57.34%-149.80%1.581.63N/AN/AN/A
GRI
GRI BIO INC
$1.31M-795.50%-345.40%-4,229.73%855.50%10.411.09N/AN/AN/A
ARWR
ARROWHEAD PHARMACEUTICALS INC
$3.03B-95.50%-38.60%-49.15%-41.00%2.823.73100.00%-163.30%-152.15%
MBIO
MUSTANG BIO INC
$3.30M-433.10%-146.40%-2,003.08%-578.20%143.240.74N/AN/AN/A
FWBI
FIRST WAVE BIOPHARMA INC
$5.27M-614.80%-284.10%-420.61%1,616.00%0.911.58N/AN/AN/A
ITRM
ITERUM THERAPEUTICS PLC
$25.46M-664.00%-87.60%-285.14%-79.40%-5.101.89N/AN/AN/A
TELO
TELOMIR PHARMACEUTICALS INC
$183.58M-1,045.40%-542.10%-332.41%-879.40%0.393.57N/AN/AN/A
CRBP
CORBUS PHARMACEUTICALS HOLDINGS INC
$406.82M-920.30%-111.60%1,150.83%-145.30%-5.100.74N/AN/AN/A
AEON
AEON BIOPHARMA INC
$64.24M-16.40%194.20%-387.59%250.50%-1.050.48N/AN/AN/A
ERNA
ETERNA THERAPEUTICS INC
$10.04M-509.00%-53.10%-49.48%-40.40%21.001.46-247.10%-31,888.20%-30,966.18%
APTO
APTOSE BIOSCIENCES INC
$18.86M-458.70%-205.30%2,245.92%5,318.80%-5.480.78N/AN/AN/A
KA
KINETA INC
$6.47M-436.00%-109.40%-428.86%652.80%2.500.85100.00%-259.10%-252.88%
EFTR
EFFECTOR THERAPEUTICS INC
$8.11MN/A-160.00%626.28%-501.80%-4.550.77N/AN/AN/A
ABVC
ABVC BIOPHARMA INC
$11.41M-224.00%-82.30%-90.73%-76.30%0.760.28-98.10%-6,898.70%-5,095.00%
SER
SERINA THERAPEUTICS INC
$20.76MN/A-120.90%-163.66%-67.90%1.210.1371.80%-10,424.60%-6,973.94%
ASLN
ASLAN PHARMACEUTICALS LTD
$7.87M-8,453.60%-95.70%-345.35%-185.20%-2.851.84100.00%-368.50%-331.29%
ARMP
ARMATA PHARMACEUTICALS INC
$90.01MN/A-65.60%-81.10%-48.50%-4.071.16100.00%-1,524.50%-1,466.53%
NVAX
NOVAVAX INC
$689.97MN/A-32.60%-325.60%106.30%-3.510.7065.10%-55.40%-53.74%
PSTV
PLUS THERAPEUTICS INC
$7.70M-805.60%-97.70%-1,954.77%307.50%-9.450.92100.00%-271.00%-263.00%
JAGX
JAGUAR HEALTH INC
$87.84M-855.60%-80.50%-94.95%-99.70%9.252.0079.10%-423.10%-357.73%
ATRA
ATARA BIOTHERAPEUTICS INC
$79.97MN/A-122.30%-1,163.44%-158.10%-2.670.72-3.70%-3,220.90%-3,159.06%
ZVSA
ZYVERSA THERAPEUTICS INC
$4.14M-287.30%-210.50%-904.02%-301.40%1.000.33N/AN/AN/A
IBIO
IBIO INC
$6.93M-197.80%-69.40%-217.92%-116.20%2.700.91100.00%-54,568.00%-54,344.00%
MAIA
MAIA BIOTECHNOLOGY INC
$65.61M-520.90%-233.20%-751.65%647.90%14.851.53N/AN/AN/A
YS
YS BIOPHARMA CO LTD
$68.68MN/AN/AN/AN/A2.180.94N/AN/AN/A
EPRX
EUPRAXIA PHARMACEUTICALS INC
N/AN/AN/A-3,110.90%N/A8.741.02N/AN/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$358.62M-159.40%-44.10%-57.85%-31.60%2.526.37N/AN/AN/A
HCWB
HCW BIOLOGICS INC
$50.31M-101.50%-67.90%-125.02%-91.00%1.120.73100.00%-4,460.40%-4,409.89%
CVM
CEL SCI CORP
$81.67M-204.30%-95.70%-127.21%-92.50%1.271.26N/AN/AN/A
HUMA
HUMACYTE INC
$525.16M-228.90%-70.50%-94.90%-116.80%8.474.52N/AN/AN/A
ACXP
ACURX PHARMACEUTICALS INC
$34.19M-289.70%-185.20%-312.38%543.80%0.652.53N/AN/AN/A
DRMA
DERMATA THERAPEUTICS INC
$2.24M-108.00%-93.60%N/A-1,532.10%0.26N/AN/AN/AN/A
ICCC
IMMUCELL CORP
$38.99M-21.80%-13.20%-14.57%-10.80%0.752.7322.10%-33.10%-33.02%
KPRX
KIORA PHARMACEUTICALS INC
$13.47M-137.30%-79.00%-102.77%-37,088.30%1.242.90N/AN/AN/A
GRTX
GALERA THERAPEUTICS INC
$10.12MN/A-137.50%-225.02%-734.50%-1.204.36N/AN/AN/A
ENGN
ENGENE HOLDINGS INC
$675.95MN/AN/AN/AN/A0.5012.97N/AN/AN/A
ELTX
ELICIO THERAPEUTICS INC
$91.91M-160.20%-102.40%-196.41%-288.20%1.391.67N/AN/AN/A
OTLK
OUTLOOK THERAPEUTICS INC
$111.91MN/A-135.10%216.49%3,441.20%-1.890.44N/AN/AN/A
SKYE
SKYE BIOSCIENCE INC
N/AN/A-438.10%1,873.67%480.70%-6.600.84N/AN/AN/A
ALLR
ALLARITY THERAPEUTICS INC
$308.95kN/A-157.50%491.11%127.20%-5.310.14N/AN/AN/A
AKTX
AKARI THERAPEUTICS PLC
$21.55M-1,281.60%-110.10%4,370.31%128.60%-20.020.95N/AN/AN/A
CNSP
CNS PHARMACEUTICALS INC
$2.35MN/A-421.40%425.02%733.20%-1.380.26N/AN/AN/A
ALZN
ALZAMEND NEURO INC
$4.99MN/A-481.20%407.14%490.20%-1.070.16N/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$20.10MN/A-194.50%255.94%548.40%-1.620.36N/AN/AN/A
CLRB
CELLECTAR BIOSCIENCES INC
$110.33MN/A-276.40%4,413.17%476.80%-9.910.81N/AN/AN/A
NRSN
NEUROSENSE THERAPEUTICS LTD
$20.45MN/A-207.30%3,205.30%762.10%-2.700.84N/AN/AN/A
PTN
PALATIN TECHNOLOGIES INC
$34.05MN/A-184.90%-1,340.67%562.20%-2.151.0995.30%-445.10%-444.90%
UNCY
UNICYCIVE THERAPEUTICS INC
$38.93MN/A-150.10%911.22%275.20%-4.730.76N/AN/AN/A
QLGN
QUALIGEN THERAPEUTICS INC
$1.90M-1,698.70%-151.60%565.58%1,134.00%-1.970.28N/AN/AN/A
BCLI
BRAINSTORM CELL THERAPEUTICS INC
$25.97MN/A-292.50%466.17%2,502.10%-1.870.24N/AN/AN/A
SLS
SELLAS LIFE SCIENCES GROUP INC
$74.84M-2,405.50%-241.00%496.81%359.50%-1.780.23N/AN/AN/A
CHRO
CHROMOCELL THERAPEUTICS CORP
$10.40MN/A-11,824.50%106.48%155.00%-1.020.02N/AN/AN/A
CING
CINGULATE INC
$4.84MN/A-432.80%337.96%-1,623.90%-1.510.06N/AN/AN/A
VCNX
VACCINEX INC
$7.45MN/A-571.70%886.21%866.60%-2.570.57100.00%-3,552.80%-3,552.63%
ENSC
ENSYSCE BIOSCIENCES INC
$4.11M-780.20%-262.40%1,641.78%2,271.70%-10.410.69N/AN/AN/A
ACHV
ACHIEVE LIFE SCIENCES INC
$162.18M-936.70%-127.70%1,869.76%-453.30%-14.380.82N/AN/AN/A
IVA
INVENTIVA SA
$171.98M-1,642.80%-119.00%-530.52%-232.90%-3.170.96100.00%-476.70%-444.40%
KTRA
KINTARA THERAPEUTICS INC
$5.89M-1,850.50%-305.80%-70,940.00%1,736.60%-12.490.63N/AN/AN/A
ATNF
180 LIFE SCIENCES CORP
$1.71M-587.20%-205.50%-11,297.22%-1,346.90%-42.180.72N/AN/AN/A
OKYO
OKYO PHARMA LTD
$38.84M-2,968.50%-279.30%642.26%725.20%-3.530.72N/AN/AN/A
BCTX
BRIACELL THERAPEUTICS CORP
$36.12MN/A-57.70%-207.41%-731.90%-2.552.99N/AN/AN/A
ANVS
ANNOVIS BIO INC
$57.04M-565.10%-326.80%-947.93%-2,533.70%-2.322.39N/AN/AN/A
CDT
CONDUIT PHARMACEUTICALS INC
$221.49MN/A-5.00%-5.97%-5.10%-16.813.18N/AN/AN/A
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD
$2.03MN/A-49.30%-84.38%-44.10%-7.904.36N/AN/AN/A
GALT
GALECTIN THERAPEUTICS INC
$206.76MN/A-197.70%-334.50%-82.00%-1.431.77N/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$89.34M-3,410.00%-291.70%-601.40%375.70%3.14N/AN/AN/AN/A
RNXT
RENOVORX INC
$20.58M-2,822.60%-258.10%-3,479.04%1,012.40%-1.491.25N/AN/AN/A
VTVT
VTV THERAPEUTICS INC
$71.13MN/A-104.90%-5,071.93%973.60%-1.201.00N/AN/AN/A
ONCO
ONCONETIX INC
$2.75M-400.10%-89.30%-52.26%2,556.90%-3.910.34-1,927.90%-63,986.50%-62,859.25%
INKT
MINK THERAPEUTICS INC
$34.01MN/A-220.60%327.84%229.90%-1.250.32N/AN/AN/A
ICU
SEASTAR MEDICAL HOLDING CORP
$33.86MN/A-914.00%263.83%12,179.70%-1.250.18N/AN/AN/A
NLSP
NLS PHARMACEUTICS LTD
$4.92MN/A-714.70%947.82%546.60%-1.530.58N/AN/AN/A
TVGN
TEVOGEN BIO HOLDINGS INC
$159.68MN/A-288.80%74.11%-266.60%-1.060.02N/AN/AN/A
OCEA
OCEAN BIOMEDICAL INC
$50.20MN/A-808.60%326.40%2,342.80%-1.010.03N/AN/AN/A
PBM
PSYENCE BIOMEDICAL LTD
$15.53M-10.10%2.00%-43.33%2.50%-1.790.01N/AN/AN/A
NKGN
NKGEN BIOTECH INC
$32.61MN/A-139.10%357.85%-172.70%-1.280.05N/AN/AN/A
CLDI
CALIDI BIOTHERAPEUTICS INC
$7.00MN/A-142.60%13,207.04%-241.90%-2.220.42N/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 6.15% over the past year, overperforming other biotech stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 65.85% from Corcept Therapeutics's current stock price of $24.52.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -20.99% over the past year, underperforming other biotech stocks by -3 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 39.37% from Incyte's current stock price of $53.76.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -92.77% over the past year, underperforming other biotech stocks by -74 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 441.87% from Amylyx Pharmaceuticals's current stock price of $2.03.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.11%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.07% in the last day, and up 6% over the last week. Ardelyx was the among the top gainers in the biotechnology industry, gaining 28.42% yesterday.

Ardelyx shares are trading higher after the company reported better-than-expected Q1 financial results.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -20.99% in the past year. It has underperformed other stocks in the biotech industry by -3 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -19.61% in the past year. It has underperformed other stocks in the biotech industry by -1 percentage points.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -92.77% in the past year. It has underperformed other stocks in the biotech industry by -74 percentage points.

Are biotech stocks a good buy now?

50.1% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 80.46% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 6.05x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.